Preventing Harmful Alcohol Use Among Trauma Patients in Cameroon
- Sponsor
- University of Buea
- Study ID
- NCT07677449
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Alcohol Use Disorder
- Alcohol-Related Injury
- Trauma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cameroon-Adapted SBIRT — BEHAVIORALA culturally adapted Screening, Brief Intervention, and Referral to Treatment (SBIRT) program delivered by trained emergency department healthcare workers. The intervention includes alcohol risk screening, brief motivational interviewing-based counseling, and referral to treatment when appropriate.
- Usual Care — OTHERStandard emergency department care without structured SBIRT delivery during the study follow-up period. Participants are offered SBIRT after completing six months of follow-up.
Study Details
\*\*Brief Summary\*\* Alcohol use is a major contributor to injury burden in Cameroon, particularly among trauma patients presenting to emergency departments. Despite the strong association between alcohol use and injury, structured alcohol screening and intervention programs are not routinely integrated into trauma care in Cameroon. This study aims to evaluate a Cameroon-adapted Screening, Brief Intervention, and Referral to Treatment (SBIRT) program for trauma patients at the Limbe Regional Hospital. The study will be conducted in three phases: (1) training emergency department healthcare providers on a culturally adapted SBIRT program; (2) evaluating the feasibility, acceptability, and fidelity of SBIRT implementation in routine emergency care; and (3) assessing the effectiveness of SBIRT in reducing harmful alcohol use among trauma patients. Healthcare workers will be trained to deliver SBIRT, and eligible trauma patients screening positive for risky alcohol use will be enrolled in a randomized waitlist-controlled trial. Participants will undergo alcohol screening using validated tools and will be followed for six months. Outcomes will include alcohol use measured by the Alcohol Use Disorders Identification Test (AUDIT), phosphatidylethanol (PEth) biomarker levels, referral uptake, implementation outcomes, and patient well-being measures. The study is expected to generate evidence on the feasibility and effectiveness of integrating alcohol interventions into trauma care in a low-resource setting and inform future scale-up of SBIRT programs in Cameroon and similar settings.
Key Dates
- First listed
- Jun 30, 2026
- Start date
- Mar 31, 2027
- Status verified
- Jun 2026
- Primary completion
- Aug 31, 2030
- Completion
- Aug 31, 2030
Study Design
- Enrollment
- 690 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Immediate SBIRTParticipants receive the Cameroon-adapted Screening, Brief Intervention, and Referral to Treatment (SBIRT) program during their emergency department visit. The intervention includes alcohol screening, personalized feedback, a brief motivational interviewing-based counseling session, and referral to treatment when indicated.
- Active Comparator: Waitlist ControlParticipants receive usual care during the follow-up period and are offered the SBIRT intervention after completion of the six-month follow-up assessment.
Primary Outcome Measure
Change in Alcohol Use at 6 Months [ Time Frame: Baseline and 6 months ]
Central Contacts
- Serge Ngekeng, PhD in Public Health+237675652562
Find similar trials
Related Studies
- Behavioral and Functional Task Development, Implementation, and TestingRecruiting · National Institute on Alcohol Abuse and Alcoholism (NIAAA) · Bethesda, Maryland
- NIAAA Natural History ProtocolRecruiting · National Institute on Alcohol Abuse and Alcoholism (NIAAA) · Bethesda, Maryland
- REVIVE: Reducing Exsanguination Via In-Vivo Expandable FoamRecruiting · Arsenal Medical, Inc. · Birmingham, Alabama
- Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSDPHASE2 · Recruiting · NYU Langone Health · New York, New York